A cross-sectional survey of stakeholders to inform the update of the British Association of Dermatologists guidelines for the safe and effective prescribing of methotrexate in dermatology

Key Points

• The research aims to collect inputs from stakeholders to enhance the methotrexate prescribing guidelines in dermatology.
• Conducted a cross-sectional survey of stakeholders including patients and healthcare professionals.
• Focused on gathering evidence regarding research priorities for guideline updates.
• Identified key research priorities among stakeholders for the methotrexate guideline.
• Engagement aided in understanding preferences for safe and effective prescribing practices.